Laddar...
Ten years’ clinical experience with biosimilar human growth hormone: a review of efficacy data
In 2006, the European Medicines Agency (EMA) approved Omnitrope(®) as a biosimilar recombinant human growth hormone (rhGH), on the basis of comparable quality, safety, and efficacy to the reference medicine (Genotropin(®), Pfizer). Data continue to be collected on the long-term efficacy of biosimila...
Sparad:
| I publikationen: | Drug Des Devel Ther |
|---|---|
| Huvudupphovsmän: | , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove Medical Press
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5439972/ https://ncbi.nlm.nih.gov/pubmed/28553079 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S130320 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|